FHIR © HL7.org  |  FHIRsmith 0.14.2  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packagede.medizininformatikinitiative.kerndatensatz.onkologie
Resource TypeMedicationStatement
IdMedicationStatement-mii-exa-onko-medikation-imatinib-atc-version-transition.json
FHIR VersionR4

Resources that use this resource

No resources found


Resources that this resource uses

No resources found


Narrative

Note: links and images are rebased to the (stated) source


English


Generated Narrative: MedicationStatement mii-exa-onko-medikation-imatinib-atc-version-transition

Profile: MII PR Onkologie Systemische Therapie Medikation version: 2027.0.0-ballot.1

basedOn: CarePlan: identifier = Tumorkonferenz_1; status = active; intent = plan; category = postoperative Tumorkonferenz (Planung der postoperativen Therapie, z. B. zur Frage adjuvante Therapie); created = 2024-01-11

partOf: Procedure Chemotherapie

status: Completed

medication: Imatinib (BCR-ABL Tyrosinkinase-Inhibitor)

subject: Erika Beispiel Female, DoB: 1965-04-12

effective: 2020-12-01 --> 2024-08-30

note:

CML-Protokoll mit Imatinib


German


Generated Narrative: MedicationStatement mii-exa-onko-medikation-imatinib-atc-version-transition

Profile: MII PR Onkologie Systemische Therapie Medikation version: 2027.0.0-ballot.1

basedOn: CarePlan: identifier = Tumorkonferenz_1; status = active; intent = plan; category = postoperative Tumorkonferenz (Planung der postoperativen Therapie, z. B. zur Frage adjuvante Therapie); created = 2024-01-11

partOf: Procedure Chemotherapie

status: Completed

medication: Imatinib (BCR-ABL Tyrosinkinase-Inhibitor)

subject: Erika Beispiel Female, DoB: 1965-04-12

effective: 2020-12-01 --> 2024-08-30

note:

CML-Protokoll mit Imatinib


Source1

{
  "resourceType": "MedicationStatement",
  "id": "mii-exa-onko-medikation-imatinib-atc-version-transition",
  "meta": {
    "profile": [
      "https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/StructureDefinition/mii-pr-onko-systemische-therapie-medikation|2027.0.0-ballot.1"
    ]
  },
  "text": {
    "status": "generated",
    "div": "<!-- snip (see above) -->"
  },
  "basedOn": [
    {
      "reference": "CarePlan/mii-exa-onko-tumorkonferenz-01"
    }
  ],
  "partOf": [
    {
      "reference": "Procedure/mii-exa-onko-systemische-therapie-1"
    }
  ],
  "status": "completed",
  "medicationCodeableConcept": {
    "coding": [
      {
        "system": "http://fhir.de/CodeSystem/bfarm/atc",
        "version": "2020",
        "code": "L01XE01",
        "display": "Imatinib"
      },
      {
        "system": "http://fhir.de/CodeSystem/bfarm/atc",
        "version": "2021",
        "code": "L01EA01",
        "display": "Imatinib"
      }
    ],
    "text": "Imatinib (BCR-ABL Tyrosinkinase-Inhibitor)"
  },
  "subject": {
    "reference": "Patient/example"
  },
  "effectivePeriod": {
    "start": "2020-12-01",
    "end": "2024-08-30"
  },
  "note": [
    {
      "text": "CML-Protokoll mit Imatinib"
    }
  ]
}